These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16043104)

  • 1. Viral IL-10-mediated immune regulation in pancreatic islet transplantation.
    Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z
    Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor immune cells in pancreatic islet transplantation.
    Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
    Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
    Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
    Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
    Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice.
    Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M
    J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-CD20 treatment prolongs syngeneic islet graft survival and delays the onset of recurrent autoimmune diabetes.
    Hu C; Deng S; Wong FS; Wen L
    Ann N Y Acad Sci; 2008 Dec; 1150():217-9. PubMed ID: 19120299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes.
    Utsugi T; Nagata M; Kawamura T; Yoon JW
    Transplantation; 1994 Jun; 57(12):1799-804. PubMed ID: 7912459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
    Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene combination transfer to block autoimmune damage in transplanted islets of Langerhans.
    Bertera S; Alexander AM; Crawford ML; Papworth G; Watkins SC; Robbins PD; Trucco M
    Exp Diabesity Res; 2004; 5(3):201-10. PubMed ID: 15512788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of donor-derived lymphocytes in the protection of pancreaticoduodenal or islet grafts from recurrent autoimmunity: a role for RT6+NKR-P1+ T cells.
    Tori M; Ito T; Kitagawa-Sakakida S; Nozawa M; Matsuda H; Shirakura R
    Transplantation; 2000 Jul; 70(1):32-8. PubMed ID: 10919571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.
    Zhang YC; Pileggi A; Agarwal A; Molano RD; Powers M; Brusko T; Wasserfall C; Goudy K; Zahr E; Poggioli R; Scott-Jorgensen M; Campbell-Thompson M; Crawford JM; Nick H; Flotte T; Ellis TM; Ricordi C; Inverardi L; Atkinson MA
    Diabetes; 2003 Mar; 52(3):708-16. PubMed ID: 12606512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice.
    Saldeen J; Sandler S; Bendtzen K; Welsh N
    Cytokine; 2000 Apr; 12(4):405-8. PubMed ID: 10805224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo controlling of cellular response to pig islet xenografts by adenovirus-mediated expression of either membrane-bound human FasL or human decoy Fas.
    Kawamoto K; Tanemura M; Deguchi T; Machida T; Nishida T; Sawa Y; Doki Y; Mori M; Ito T
    Transplant Proc; 2009; 41(1):331-3. PubMed ID: 19249549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
    Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
    Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.